MOLD PREVENTION Sample Clauses

MOLD PREVENTION. Xxxxxxxx has inspected the Leased Property prior to the commencement of the Lease Agreement and has identified no damp or wet building materials and knows of no mold, mildew or other fungal growth in the Leased Property. However, mold and mildew spores are present throughout the natural environment and cannot be entirely eliminated from a Leased Property. Precautions regarding mold need to be taken by Tenant at all times during the Lease Term. In order to reduce the probability of mold, mildew or other fungal growth, protect your health and protect your personal property and the Leased Property, Xxxxxx agrees to maintain the Leased Property in a clean and orderly manner that prevents the growth of mold, mildew or other fungi in the Leased Property by reducing or eliminating the sources of excess moisture. In recognition of the foregoing, the Tenant covenants and agrees:
Sample 1Sample 2
MOLD PREVENTION. Owner’s goal is to provide a quality living environment for its residents. To help achieve this goal, it is important we work together to minimize any mold growth in your apartment. This provision contains important information on how to achieve this goal, and sets forth Resident’s and Owner’s responsibilities.
Sample 1Sample 2
MOLD PREVENTION. Because mold spores are present essentially everywhere and mold can grow in almost any moist location, Tenant acknowledges the necessity of adopting and enforcing good housekeeping practices, ventilation and vigilant moisture control within the Premises (particularly in kitchen areas, janitorial closets, bathrooms, in and around water fountains and other plumbing facilities and fixtures, break rooms, in and around outside walls, and in and around HVAC systems and associated drains) for the prevention of mold (such measures, Mold Prevention Practices"). Tenant will, at its sole cost and expense keep and maintain the Building in good order and condition in accordance with the Mold Prevention Practices and acknowledges that the control of moisture, and prevention of "Mold Conditions," as defined in Section 30.6.2.1, below, within the Premises, are integral to its obligations under this Lease.
Sample 1
MOLD PREVENTION. In an effort to reduce the occurrence of mold Resident must monitor moisture accumulation. If Resident notices any mold in premises, Resident must notify the Landlord immediately. It is the Resident’s responsibility to clean the mold and treat it with a proper mold and mildew remover. It is the Resident’s responsibility to ventilate the premises properly in an effort to reduce mold accumulation. Resident may review mold addendum at our website, xxx.xxxxxxxxxxxxxxxxxxxx.xxx. Voter Registration For Resident's convenience, Resident may go to our website, xxx.xxxxxxxxxxxxxxxxxxxx.xxx, go to the Resident Forms tab and click on the link to complete the on-line application. Common Areas If an apartment or condominium, the Premises consist of the interior of the apartment. Regardless of whether they are assigned for Resident’s use, all exterior access ways, decks, planting areas, patios, parking and storage spaces are common areas of the Property and are not part of the Premises. Whenever Landlord assigns such areas for Resident’s use, said usage is a license to use in common with Landlord. All Resident's obligations pursuant to this Agreement shall extend to said storage locker and/or parking space(s). Resident recognizes that their storage of any personal property on the Premises is at their own risk. Resident hereby releases Landlord and agent from any and all claims for damages arising out of the loss or damage to goods in storage for whatever reason.
Sample 1
MOLD PREVENTION. Tenant agrees to maintain the Premises in a manner that prevents the occurrence of an infestation of mold, mildew, microbial growths, and any associated mycotoxin (Mold) in the Premises. Tenant agrees to use reasonable efforts to:
Sample 1
MOLD PREVENTION. Landlord has inspected the unit prior to Tenant occupancy and observed no mold or mildew presence. Tenant acknowledges that mold can develop if the residence is not properly cleaned or ventilated during the tenancy and if moisture is allowed to accumulate. Tenant agrees to allow air to regularly circulate in the unit by such means as opening windows, running fans, etc. Additional Mold Prevention Documentation has been provided to the Tenant. Initial Initial
Sample 1
AutoNDA by SimpleDocs
MOLD PREVENTION. The Tenant shall use reasonable efforts to prevent the accumulation of moisture and the growth of mold. Such prevention includes running the bathroom fan or opening the bathroom window during & after a shower or bath. Air circulation with heat is most effective. Also, window surfaces and surrounding areas need to be kept clean and dry.
Sample 1

Related to MOLD PREVENTION

  • Anti-Money Laundering and Red Flag Identity Theft Prevention Programs The Trust acknowledges that it has had an opportunity to review, consider and comment upon the written procedures provided by USBFS describing various tools used by USBFS which are designed to promote the detection and reporting of potential money laundering activity by monitoring certain aspects of shareholder activity as well as written procedures for verifying a customer’s identity (collectively, the “Procedures”). Further, the Trust has determined that the Procedures, as part of the Trust’s overall anti-money laundering program and the Red Flag Identity Theft Prevention program, are reasonably designed to prevent the Fund from being used for money laundering or the financing of terrorist activities and to achieve compliance with the applicable provisions of the Fair and Accurate Credit Transactions Act of 2003 and the USA Patriot Act of 2001 and the implementing regulations thereunder. Based on this determination, the Trust hereby instructs and directs USBFS to implement the Procedures on the Trust’s behalf, as such may be amended or revised from time to time. It is contemplated that these Procedures will be amended from time to time by the parties as additional regulations are adopted and/or regulatory guidance is provided relating to the Trust’s anti-money laundering and identity theft responsibilities. USBFS agrees to provide to the Trust:

  • Clinical Data and Regulatory Compliance The preclinical tests and clinical trials conducted by the Company, and to the knowledge of the Company, the preclinical tests and clinical trials conducted on behalf of or sponsored by the Company, that are described in, or the results of which are referred to in, the Registration Statement, the Time of Sale Prospectus or the Prospectus were and, if still pending, are being conducted in all material respects in accordance with the protocols, procedures and controls designed and approved for such studies and with standard medical and scientific research procedures and all applicable laws and regulations, including, without limitation, 21 C.F.R. Parts 50, 54, 56, 58, and 312; each description of the results of such studies is accurate and complete in all material respects and fairly presents the data derived from such studies, and the Company and its subsidiaries have no knowledge of any other studies the results of which are inconsistent with, or otherwise call into question, the results described or referred to in the Registration Statement, the Time of Sale Prospectuses or the Prospectus; the Company and its subsidiaries have made all such filings and obtained all such Permits as may be required by the Food and Drug Administration of the U.S. Department of Health and Human Services or any committee thereof or from any other U.S. or foreign government or drug or medical device regulatory agency, or health care facility Institutional Review Board (collectively, the “Regulatory Agencies”) for the operation of the Company’s business as currently conducted, except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; neither the Company nor any of its subsidiaries has received any notice of, or correspondence from, any Regulatory Agency requiring the termination, suspension or modification of any clinical trials that are described or referred to in the Registration Statement, the Time of Sale Prospectus or the Prospectus; and the Company and its subsidiaries have each operated and currently are in compliance in all material respects with all applicable rules and regulations of the Regulatory Agencies except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

  • SAFETY AND HEALTH 20.1 The Employer, employee and Union have a significant responsibility for workplace safety and health.

Time is Money Join Law Insider Premium to draft better contracts faster.